FDA decision on Novavax’s Covid shots could be delayed to review changes in manufacturing

The Food and Drug Administration said it needs to review changes to Novavax's manufacturing before deciding whether to authorize its Covid-19 vaccine in the U.S.The FDA's committee recommended the Novavax vaccine for use in the U.S. on Tuesday.The FDA is not obligated to follow the committee's recommendation, though the agency normally does so.

MAYDAY Washington: current affairs

See author's posts